Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$12.00 USD
-1.62 (-11.89%)
Updated Apr 18, 2024 03:59 PM ET
After-Market: $12.00 0.00 (0.00%) 4:28 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-1.18 | 0.00% |
Earnings Summary
For their last quarter, Avalo Therapeutics (AVTX) reported earnings of -$26.19 per share, beating the Zacks Consensus Estimate of $-261.90 per share. This reflects a positive earnings surprise of 90.00%. Look out for AVTX's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.18 per share, reflecting a year-over-year increase of 99.42%.
Earnings History
Price & Consensus
Zacks News for AVTX
Will Avalo Therapeutics, Inc. (AVTX) Report Negative Q4 Earnings? What You Should Know
AVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services